Record NNP B-NP O
date NN I-NP O
: : O O
2096-03-10 CD O B-DATE
HALL NNP B-NP I-PATIENT
, , O I-PATIENT
NICK NNP B-NP I-PATIENT
65219816 CD O B-MEDICALRECORD
03/10/2096 CD O B-DATE
Youssef NNP B-NP B-DOCTOR
Nall NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
Ludlow NNP B-NP B-HOSPITAL
Medical NNP I-NP I-HOSPITAL
Center NNP I-NP I-HOSPITAL
45 CD B-NP B-STREET
Wilder NNP I-NP I-STREET
St NNP I-NP I-STREET
Post NNP B-NP B-CITY
, , O O
IN IN B-PP B-STATE
86454 CD B-NP B-ZIP
Dear NNP B-NP O
Dr. NNP I-NP O
Nall NNP I-NP B-DOCTOR
: : O O
It PRP B-NP O
was VBD B-VP O
a DT B-NP O
pleasure NN I-NP O
to TO B-VP O
see VB I-VP O
Nick NNP B-NP B-PATIENT
Hall NNP I-NP I-PATIENT
again RB B-ADVP O
in IN B-PP O
the DT B-NP O
Cardiology NNP I-NP O
clinic NN I-NP O
at IN B-PP O
Wytheville NNP B-NP B-HOSPITAL
South NNP I-NP I-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
in IN B-PP O
followup NN B-NP O
of IN B-PP O
his PRP$ B-NP O
post NN I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
care NN I-NP O
. . O O
As IN B-SBAR O
you PRP B-NP O
are VBP B-VP O
well RB B-ADJP O
aware JJ I-ADJP O
, , O O
he PRP B-NP O
has VBZ B-VP O
many JJ B-NP O
coronary JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
a DT B-NP O
55 CD I-NP B-AGE
-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-PP O
past JJ B-NP O
history NN I-NP O
Hodgkin NNP I-NP O
's POS B-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
mantle NN I-NP O
radiation NN I-NP O
in IN B-PP O
the DT B-NP O
early JJ I-NP O
2070s CD I-NP B-DATE
and CC O O
left VBD B-VP O
upper JJ B-NP O
lobe NN I-NP O
lobectomy NN I-NP O
in IN B-PP O
2094 CD B-NP B-DATE
for IN B-PP O
early JJ B-NP O
stage NN I-NP O
squamous JJ I-NP O
cell NN I-NP O
lung NN I-NP O
cancer NN I-NP O
that WDT B-NP O
was VBD B-VP O
complicated VBN I-VP O
by IN B-PP O
VT/VF NNP B-NP O
arrest NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
history NN B-NP O
of IN B-PP O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
overweight JJ B-NP O
. . O O
He PRP B-NP O
does VBZ B-VP O
not RB I-VP O
have VB I-VP O
a DT B-NP O
former JJ I-NP O
history NN I-NP O
of IN B-PP O
type NN B-NP O
2 CD I-NP O
diabetes NN I-NP O
, , O O
but CC O O
on IN B-PP O
recent JJ B-NP O
screening NN I-NP O
, , O O
his PRP$ B-NP O
hemoglobin NN I-NP O
A1c NNP B-NP O
has VBZ B-VP O
been VBN I-VP O
elevated VBN I-VP O
at IN B-PP O
8 CD B-NP O
% NN I-NP O
. . O O
His PRP$ B-NP O
prior JJ I-NP O
history NN I-NP O
of IN B-PP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
dates VBZ B-VP O
back RB B-ADVP O
to TO B-PP O
2087 CD B-NP B-DATE
and CC O O
2090 CD B-NP B-DATE
when WRB B-ADVP O
he PRP B-NP O
had VBD B-VP O
non-ST JJ B-NP O
elevation NN I-NP O
MI NNP I-NP O
and CC I-NP O
coronary JJ I-NP O
interventions NNS I-NP O
to TO B-PP O
his PRP$ B-NP O
LAD NN I-NP O
and CC I-NP O
RCA NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
subsequently RB I-VP O
had VBD I-VP O
a DT B-NP O
VT/VF NN I-NP O
arrest NN I-NP O
during IN B-PP O
his PRP$ B-NP O
lobectomy NN I-NP O
in IN B-PP O
2094 CD B-NP B-DATE
, , O O
which WDT B-NP O
required VBD B-VP O
emergent NN B-NP O
coronary JJ I-NP O
angiographic JJ I-NP O
resuscitation NN I-NP O
where WRB B-ADVP O
he PRP B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
massive JJ I-NP O
thrombus NN I-NP O
throughout IN B-PP O
his PRP$ B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
that WDT B-NP O
required VBD B-VP O
thrombectomy NN B-NP O
and CC I-NP O
POBA NNP I-NP O
with IN B-PP O
good JJ B-NP O
results NNS I-NP O
. . O O
He PRP B-NP O
remarkably RB B-ADVP O
has VBZ B-VP O
had VBN I-VP O
a DT B-NP O
preserved VBD I-NP O
LV NNP I-NP O
function NN I-NP O
after IN B-PP O
all DT B-NP O
of IN B-PP O
these DT B-NP O
infarctions NNS I-NP O
with IN B-PP O
only RB B-NP O
some DT I-NP O
basal NN I-NP O
inferoposterior JJ I-NP O
hypokinesis NN I-NP O
. . O O
In IN B-PP O
01/2095 CD B-NP B-DATE
, , O O
he PRP B-NP O
developed VBD B-VP O
recurrent JJ B-NP O
exertional JJ I-NP O
and CC I-NP O
then RB I-NP O
unstable JJ I-NP O
angina NN I-NP O
, , O O
presented VBN B-VP O
to TO B-PP O
Wytheville NNP B-NP B-HOSPITAL
Sanitarium NNP I-NP I-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
Emergency NNP I-NP O
where WRB B-ADVP O
he PRP B-NP O
was VBD B-VP O
considered VBN I-VP O
to TO I-VP O
be VB I-VP O
high JJ B-NP O
risk NN I-NP O
acute JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
syndrome NN I-NP O
with IN B-PP O
positive JJ B-NP O
troponins NNS I-NP O
and CC O O
proceeded VBD B-VP O
to TO B-PP O
the DT B-NP O
catheterization NN I-NP O
clinic NN I-NP O
where WRB B-ADVP O
he PRP B-NP O
again RB B-ADVP O
had VBD B-VP O
proximal JJ B-NP O
LAD NN I-NP O
and CC I-NP O
RCA NNP I-NP O
occlusions NNS I-NP O
, , O O
both DT B-NP O
which WDT B-NP O
were VBD B-VP O
intervened VBN I-VP O
with IN B-PP O
drug-eluting JJ B-NP O
Cypher NNP I-NP O
stents NNS I-NP O
with IN B-PP O
good JJ B-NP O
results NNS I-NP O
. . O O
Since IN O O
then RB B-ADVP O
, , O O
he PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
doing VBG I-VP O
well RB B-ADVP O
and CC O O
has VBZ B-VP O
been VBN I-VP O
instructed VBN I-VP O
to TO I-VP O
be VB I-VP O
on IN B-PP O
double JJ B-NP O
dose NN I-NP O
clopidogrel NN I-NP O
150 CD B-NP O
mg NN I-NP O
lifelong JJ I-NP O
and CC I-NP O
full JJ I-NP O
dose NN I-NP O
aspirin NN I-NP O
325 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
lifelong RB I-ADVP O
. . O O
We PRP B-NP O
see VBP B-VP O
him PRP B-NP O
in IN B-PP O
followup NN B-NP O
today NN I-NP O
, , O O
and CC O O
again RB B-ADVP O
, , O O
he PRP B-NP O
has VBZ B-VP O
no DT B-NP O
limitations NNS I-NP O
in IN B-PP O
his PRP$ B-NP O
exertional JJ I-NP O
capacity NN I-NP O
. . O O
Work NN B-NP O
has VBZ B-VP O
been VBN I-VP O
tough JJ B-ADJP O
in IN B-PP O
consulting VBG B-VP B-PROFESSION
and CC O O
he PRP B-NP O
is VBZ B-VP O
now RB I-VP O
working VBG I-VP O
2 CD B-NP O
jobs NNS I-NP O
including VBG B-VP O
overnight JJ B-NP O
shifts NNS I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
strenuous JJ B-ADJP O
at IN B-PP O
times NNS B-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
looking VBG I-VP O
for IN B-PP O
work NN B-NP O
as IN B-PP O
a DT B-NP O
dog NN I-NP B-PROFESSION
walker NN I-NP I-PROFESSION
and CC O O
will MD B-VP O
find VB I-VP O
out RP B-ADVP O
soon RB I-ADVP O
whether IN B-SBAR O
he PRP B-NP O
can MD B-VP O
quit VB I-VP O
his PRP$ B-NP O
evening NN I-NP O
jobs NNS I-NP O
and CC O O
will MD B-VP O
be VB I-VP O
able JJ B-ADJP O
to TO B-VP O
increase VB I-VP O
his PRP$ B-NP O
exercise NN I-NP O
capacity NN I-NP O
such JJ B-VP O
that IN B-SBAR O
he PRP B-NP O
will MD B-VP O
be VB I-VP O
doing VBG I-VP O
more RBR B-NP O
walking VBG I-NP O
with IN B-PP O
that DT B-NP O
job NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
presyncope NN B-NP O
, , O O
or CC O O
syncope NN B-NP O
with IN B-PP O
exertion NN B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
signs NNS I-NP O
or CC I-NP O
symptoms NNS I-NP O
of IN B-PP O
heart NN B-NP O
failure NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
taking VBG I-VP O
his PRP$ B-NP O
blood NN I-NP O
pressures NNS I-NP O
at IN B-PP O
home NN B-NP O
, , O O
which WDT B-NP O
range VBP B-VP O
at IN B-PP O
about IN B-NP O
126/8 CD I-NP O
1 CD I-NP O
to TO B-PP O
142/92 CD B-NP O
with IN B-PP O
an DT B-NP O
average NN I-NP O
of IN B-PP O
135/85 CD B-NP O
. . O O
His PRP$ B-NP O
heart NN I-NP O
rates NNS I-NP O
have VBP B-VP O
been VBN I-VP O
in IN B-PP O
50s-70s NNS B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
no DT B-NP O
side NN I-NP O
effects NNS B-VP O
to TO B-PP O
his PRP$ B-NP O
medications NNS I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
not RB I-VP O
smoking VBG I-VP O
and CC O O
he PRP B-NP O
is VBZ B-VP O
not RB I-VP O
drinking VBG I-VP O
alcohol NN B-NP O
. . O O
He PRP B-NP O
says VBZ B-VP O
that IN B-SBAR O
he PRP B-NP O
walks VBZ B-VP O
for IN B-NP O
2-3 CD I-NP O
miles NNS I-NP O
when WRB B-ADVP O
the DT B-NP O
weather NN I-NP O
is VBZ B-VP O
nice JJ B-ADJP O
, , O O
but CC O O
given VBN B-VP O
that IN B-SBAR O
it PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
a DT B-NP O
harsh JJ I-NP O
winter NN I-NP B-DATE
, , O O
he PRP B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
doing VBG I-VP O
this DT B-NP O
often RB B-ADVP O
. . O O
His PRP$ B-NP O
current JJ I-NP O
medications NNS I-NP O
, , O O
aspirin RB B-ADVP O
325 CD B-NP O
mg JJ I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
, , O O
clopidogrel NN B-NP O
150 CD I-NP O
mg NN I-NP O
p.o RB B-ADVP O
. . O O
daily JJ B-ADVP O
, , O O
atorvastatin IN B-SBAR O
80 CD B-NP O
mg JJ I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
, , O O
levothyroxine NN B-NP O
125 CD I-NP O
mcg NN I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
, , O O
and CC O O
metoprolol NN B-NP O
sustained VBD B-VP O
release NN B-NP O
200 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
b.i.d '' O O
. . O O
Physical JJ B-NP O
Examination NNP I-NP O
: : O O
Nick NNP B-NP B-PATIENT
looked VBD B-VP O
well RB B-ADVP O
. . O O
His PRP$ B-NP O
weight NN I-NP O
was VBD B-VP O
232 CD B-NP O
pounds NNS I-NP O
, , O O
his PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
153/89 CD B-NP O
in IN B-PP O
the DT B-NP O
right JJ I-NP O
arm NN I-NP O
and CC O O
150/95 CD B-NP O
in IN B-PP O
the DT B-NP O
left JJ I-NP O
arm NN I-NP O
with IN B-PP O
a DT B-NP O
large JJ I-NP O
cuff NN I-NP O
, , O O
and CC O O
his PRP$ B-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
69 CD B-NP O
and CC I-NP O
regular JJ I-NP O
. . O O
His PRP$ B-NP O
head NN I-NP O
and CC I-NP O
neck NN I-NP O
exam NN I-NP O
revealed VBD B-VP O
normal JJ B-ADJP O
jugular RB B-NP O
venous JJ I-NP O
pressure NN I-NP O
and CC O O
normal JJ B-NP O
carotid NN I-NP O
upstroke NN I-NP O
and CC I-NP O
contour NN I-NP O
. . O O
There EX B-NP O
are VBP B-VP O
no DT B-NP O
bruits NNS I-NP O
. . O O
His PRP$ B-NP O
chest NN I-NP O
is VBZ B-VP O
clear JJ B-ADJP O
to TO B-PP O
auscultation NN B-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
not RB I-VP O
clubbed VBN I-VP O
. . O O
His PRP$ B-NP O
cardiovascular JJ I-NP O
exam NN I-NP O
revealed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
left NN I-NP O
apex NN I-NP O
and CC O O
normal JJ B-NP O
S1 NN I-NP O
and CC I-NP O
S2 NN I-NP O
with IN B-PP O
no DT B-NP O
additional JJ I-NP O
gallops NNS I-NP O
, , O O
rubs NNS B-NP O
, , O O
or CC O O
murmurs NNS B-NP O
. . O O
He PRP B-NP O
had VBD B-VP O
no DT B-NP O
peripheral JJ I-NP O
edema NN I-NP O
. . O O
His PRP$ B-NP O
abdomen NN I-NP O
was VBD B-VP O
soft JJ B-ADJP O
and CC O O
nontender NN B-NP O
with IN B-PP O
no DT B-NP O
organomegaly NN I-NP O
. . O O
His PRP$ B-NP O
pulses NNS I-NP O
were VBD B-VP O
palpable JJ B-ADJP O
2+ JJ I-ADJP O
throughout IN B-PP O
. . O O
EKG NNP B-NP O
: : O O
Normal JJ B-ADJP O
sinus IN B-PP O
rhythm NN B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
61 CD B-NP O
, , O O
minimal JJ B-NP O
voltage NN I-NP O
criteria NNS I-NP O
for IN B-PP O
LVH NNP B-NP O
and CC O O
left VBD B-VP O
atrial JJ B-NP O
enlargement NN I-NP O
. . O O
Prior RB O O
inferior JJ B-NP O
Q-wave NNP I-NP O
MI NNP I-NP O
. . O O
Lab NNP B-NP O
values NNS I-NP O
from IN B-PP O
today NN B-NP O
: : O O
His PRP$ B-NP O
electrolyte JJ I-NP O
panel NN I-NP O
was VBD B-VP O
notable JJ B-ADJP O
for IN B-PP O
sodium NN B-NP O
144 CD I-NP O
, , O O
potassium NN B-NP O
4.1 CD I-NP O
, , O O
chloride NN B-NP O
107 CD I-NP O
, , O O
bicarb NN B-NP O
28 CD I-NP O
, , I-NP O
creatinine CD I-NP O
1 CD I-NP O
, , I-NP O
urea NN I-NP O
16 CD B-NP O
, , O O
normal JJ B-NP O
calcium NN I-NP O
, , O O
normal JJ B-NP O
LFTs NNS I-NP O
, , O O
and CC O O
normal JJ B-NP O
CK NN I-NP O
level NN I-NP O
. . O O
TSH NNP B-NP O
was VBD B-VP O
also RB B-ADJP O
normal JJ I-ADJP O
. . B-NP O
Hemoglobin NNP I-NP O
A1c NNP I-NP O
was VBD B-VP O
elevated VBN I-VP O
at IN B-PP O
6.8 CD B-NP O
% NN I-NP O
. . O O
Lipid JJ B-NP O
levels NNS I-NP O
: : O O
Total JJ B-NP O
cholesterol NN I-NP O
164 VBD B-VP O
, , O O
TG NNP B-NP O
145 CD I-NP O
, , O O
HDL NNP B-NP O
33 CD I-NP O
, , O O
LDL NNP B-NP O
102 CD I-NP O
. . O O
Echocardiogram NNP B-NP O
from IN B-PP O
last JJ B-NP O
year NN I-NP O
revealed VBD B-VP O
normal JJ B-NP O
LV RB I-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-PP O
60%-65 CD B-NP O
% NN I-NP O
. . O O
Mild NNP B-NP O
left VBD B-VP O
atrial JJ B-NP O
enlargement NN I-NP O
, , O O
no DT B-NP O
LVH. NNP I-NP O
Impression NN B-NP O
: : O O
Nick NNP B-NP B-PATIENT
is VBZ B-VP O
still RB B-ADVP O
borderline JJ B-ADJP O
hypertensive JJ I-ADJP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
setting NN I-NP O
of IN B-PP O
having VBG B-VP O
survived VBN I-VP O
multiple JJ B-NP O
myocardial JJ I-NP O
infarctions NNS I-NP O
, , O O
Hodgkin NNP B-NP O
lymphoma NN I-NP O
and CC O O
now RB B-VP O
declaring VBG I-VP O
himself PRP B-NP O
as IN B-PP O
potential JJ B-NP O
glucose NN I-NP O
intolerant NN I-NP O
and CC O O
early JJ B-NP O
diabetic NN I-NP O
, , O O
I PRP B-NP O
think VBP B-VP O
it PRP B-NP O
is VBZ B-VP O
time NN B-NP O
to TO B-VP O
start VB I-VP O
an DT B-NP O
ACE NNP I-NP O
inhibitor NN I-NP O
as IN B-SBAR O
we PRP B-NP O
have VBP B-VP O
discussed VBN I-VP O
previously RB B-ADVP O
. . O O
We PRP B-NP O
started VBD B-VP O
him PRP B-NP O
on IN B-PP O
ramipril NNP B-NP O
2.5 CD I-NP O
mg NN I-NP O
today NN I-NP O
and CC O O
he PRP B-NP O
will MD B-VP O
increase VB I-VP O
that IN B-NP O
to TO B-PP O
5 CD B-NP O
mg CD I-NP O
a DT B-NP O
day NN I-NP O
after IN B-PP O
tolerating VBG B-VP O
it PRP B-NP O
for IN B-PP O
2 CD B-NP O
weeks NNS I-NP O
. . O O
He PRP B-NP O
will MD B-VP O
take VB I-VP O
his PRP$ B-NP O
blood NN I-NP O
pressures NNS I-NP O
at IN B-PP O
home NN B-NP O
few JJ I-NP O
times NNS I-NP O
a DT B-NP O
week NN I-NP O
. . O O
To TO B-VP O
simplify VB I-VP O
and CC I-VP O
decrease VB I-VP O
his PRP$ B-NP O
beta-blocker NN I-NP O
regimen RB B-ADVP O
we PRP B-NP O
switched VBD B-VP O
to TO I-VP O
atenolol VB I-VP O
100mg JJ B-NP O
daily JJ I-NP O
today NN I-NP O
. . O O
We PRP B-NP O
also RB B-ADVP O
discussed VBD B-VP O
increasing VBG I-VP O
his PRP$ B-NP O
lipid JJ I-NP O
management NN I-NP O
by IN B-PP O
adding VBG B-VP O
niacin NN B-NP O
again RB B-VP O
starting VBG I-VP O
at IN B-PP O
500 CD B-NP O
mg NN I-NP O
extended VBD B-VP O
release NN B-NP O
for IN B-PP O
a DT B-NP O
month NN I-NP O
and CC O O
then RB B-ADVP O
he PRP B-NP O
will MD B-VP O
increase VB I-VP O
that IN B-NP O
to TO I-NP O
1 CD I-NP O
g NN I-NP O
a DT B-NP O
day NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
cautioned VBD I-VP O
on IN B-PP O
the DT B-NP O
adverse JJ I-NP O
potential JJ I-NP O
reactions NNS I-NP O
of IN B-PP O
facial JJ B-NP O
flushing NN I-NP O
and CC O O
headache NN B-NP O
and CC O O
he PRP B-NP O
was VBD B-VP O
instructed VBN I-VP O
to TO I-VP O
take VB I-VP O
his PRP$ B-NP O
aspirin NN I-NP O
325 CD I-NP O
about IN B-PP O
30 CD B-NP O
minute NN I-NP O
prior JJ B-ADJP O
to TO B-PP O
his PRP$ B-NP O
niacin NN I-NP O
to TO B-VP O
minimize VB I-VP O
these DT B-NP O
potential JJ I-NP O
side NN I-NP O
effects NNS I-NP O
. . O O
With IN B-SBAR O
regards NNS B-NP O
to TO B-PP O
his PRP$ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
all PDT B-NP O
this DT I-NP O
time NN I-NP O
we PRP B-NP O
have VBP B-VP O
assumed VBN I-VP O
that IN B-PP O
his PRP$ B-NP O
atherosclerosis NN I-NP O
has VBZ B-VP O
been VBN I-VP O
secondary JJ B-ADJP O
to TO B-PP O
high JJ B-NP O
dose NN I-NP O
radiation NN I-NP O
exposure NN I-NP O
when WRB B-ADVP O
he PRP B-NP O
was VBD B-VP O
a DT B-NP O
child NN I-NP O
. . B-VP O
Nevertheless RB B-ADVP O
, , O O
Dr. NNP B-NP O
Turner NNP I-NP B-DOCTOR
had VBD B-VP O
a DT B-NP O
great JJ I-NP O
suggestion NN I-NP O
that IN B-SBAR O
we PRP B-NP O
screen VB B-VP O
him PRP B-NP O
for IN B-PP O
quantitative JJ B-NP O
platelet NN I-NP O
function NN I-NP O
inhibition NN I-NP O
, , O O
given VBN B-VP O
we PRP B-NP O
recently RB B-ADVP O
started VBD B-VP O
performing VBG I-VP O
this DT B-NP O
test NN I-NP O
at IN B-PP O
WSH NNP B-NP B-HOSPITAL
and CC O O
previously RB B-VP O
had VBD I-VP O
recurrence NN B-NP O
on IN B-PP O
normal JJ B-NP O
strength NN I-NP O
doses NNS I-NP O
of IN B-PP O
clopidogrel NN B-NP O
and CC I-NP O
aspirin NN I-NP O
. . O O
The DT B-NP O
results NNS I-NP O
may MD B-VP O
not RB O O
changes NNS B-VP O
our PRP$ B-NP O
current JJ I-NP O
management NN I-NP O
strategy NN I-NP O
, , O O
but CC O O
it PRP B-NP O
may MD B-VP O
give VB I-VP O
us PRP B-NP O
insight NN B-NP O
into IN B-PP O
his PRP$ B-NP O
premature JJ I-NP O
CAD NN I-NP O
etiology NN I-NP O
, , O O
particularly RB B-ADVP O
coronary JJ B-NP O
artery NN I-NP O
thrombus NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
play NN B-VP O
a DT B-NP O
future JJ I-NP O
role NN I-NP O
in IN B-PP O
familial JJ B-NP O
screening NN I-NP O
. . O O
To TO B-PP O
that DT B-NP O
end NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
requested VBN I-VP O
light NN B-NP O
transmission NN I-NP O
aggregometry NN I-NP O
for IN B-PP O
platelet NN B-NP O
function NN I-NP O
inhibition VBZ B-VP O
. . O O
We PRP B-NP O
have VBP B-VP O
also RB I-VP O
requested VBN I-VP O
a DT B-NP O
thrombophilia NN I-NP O
workup NN I-NP O
, , O O
including VBG B-PP O
factor NN B-NP O
V NNP I-NP O
Leiden NNP I-NP O
, , O O
prothrombin VBG B-VP O
gene NN B-NP O
mutation NN I-NP O
, , O O
protein NN B-NP O
C NNP I-NP O
and CC I-NP O
S NNP I-NP O
levels NNS I-NP O
, , O O
antithrombin IN B-PP O
level NN B-NP O
and CC I-NP O
homocysteine NN I-NP O
and CC O O
CRP NNP B-NP O
today NN B-NP O
. . O O
Otherwise RB B-ADVP O
, , O O
I PRP B-NP O
believe VBP B-VP O
Nick NNP B-NP B-PATIENT
is VBZ B-VP O
doing VBG I-VP O
well RB B-ADVP O
. . O O
We PRP B-NP O
will MD B-VP O
see VB I-VP O
him PRP B-NP O
again RB B-ADVP O
in IN B-PP O
6 CD B-NP O
months NNS I-NP O
' POS B-NP O
time NN I-NP O
with IN B-PP O
follow VB B-VP O
up RP B-PRT O
on IN B-PP O
these DT B-NP O
studies NNS I-NP O
. . O O
If IN B-ADVP O
by IN B-PP O
then RB B-ADVP O
he PRP B-NP O
still RB B-ADVP O
has VBZ B-VP O
evidence NN B-NP O
of IN B-PP O
diabetes NNS B-NP O
, , O O
and CC O O
trouble NN B-NP O
losing VBG B-VP O
weight NN B-NP O
, , O O
we PRP B-NP O
will MD B-VP O
refer VB I-VP O
him PRP B-NP O
to TO B-PP O
our PRP$ B-NP O
nutritionist NN I-NP O
for IN B-PP O
counseling NN B-NP O
and CC O O
refer VB B-VP O
him PRP B-NP O
to TO B-VP O
hadley VB I-VP B-HOSPITAL
memorial JJ B-NP I-HOSPITAL
hospital NN I-NP I-HOSPITAL
. . B-NP O
He PRP B-NP O
may MD B-VP O
need VB I-VP O
a DT B-NP O
structured JJ I-NP O
monitored JJ I-NP O
exercise NN I-NP O
program NN I-NP O
in IN B-SBAR O
order NN O O
to TO B-VP O
help VB I-VP O
improve VB I-VP O
his PRP$ B-NP O
exercise NN I-NP O
capacity NN I-NP O
. . O O
This DT B-NP O
patient NN I-NP O
was VBD B-VP O
discussed VBN I-VP O
with IN B-PP O
Dr. NNP B-NP O
Turner NNP I-NP B-DOCTOR
in IN B-PP O
clinic NN B-NP O
. . O O
Yours PRP B-NP O
sincerely RB B-ADVP O
, , O O
Dictated VBN B-VP O
by IN B-PP O
: : O O
Yisroel NNP B-NP B-DOCTOR
F NNP I-NP I-DOCTOR
Cooley NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
MPH NNP I-NP O
FRCPC NNP I-NP O
Email NN B-NP O
: : O O
yfcooley@wsh NN B-NP I-EMAIL
.org . O I-EMAIL
Paul NNP B-NP B-DOCTOR
Turner NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
ATTENDING VBG O O
eScription NN B-NP O
document NN I-NP O
: : O O
8-4867586 CD B-NP B-IDNUM
HFFocus NN I-NP O
DD NNP B-NP O
: : O O
03/10/96 CD O B-DATE
DT NNP B-NP O
: : O O
03/11/96 CD O B-DATE
DV NNP B-NP O
: : O O
03/10/96 CD O B-DATE
